IL79816A - Pharmaceutical compositions comprising a drug-polymer matrix - Google Patents

Pharmaceutical compositions comprising a drug-polymer matrix

Info

Publication number
IL79816A
IL79816A IL79816A IL7981686A IL79816A IL 79816 A IL79816 A IL 79816A IL 79816 A IL79816 A IL 79816A IL 7981686 A IL7981686 A IL 7981686A IL 79816 A IL79816 A IL 79816A
Authority
IL
Israel
Prior art keywords
drug
polymer matrix
pharmaceutical compositions
media
active ingredient
Prior art date
Application number
IL79816A
Other languages
English (en)
Other versions
IL79816A0 (en
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25084045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL79816(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Searle & Co filed Critical Searle & Co
Publication of IL79816A0 publication Critical patent/IL79816A0/xx
Publication of IL79816A publication Critical patent/IL79816A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL79816A 1985-08-26 1986-08-22 Pharmaceutical compositions comprising a drug-polymer matrix IL79816A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76898185A 1985-08-26 1985-08-26

Publications (2)

Publication Number Publication Date
IL79816A0 IL79816A0 (en) 1986-11-30
IL79816A true IL79816A (en) 1990-11-05

Family

ID=25084045

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79816A IL79816A (en) 1985-08-26 1986-08-22 Pharmaceutical compositions comprising a drug-polymer matrix

Country Status (16)

Country Link
EP (1) EP0212641B1 (de)
JP (1) JPH0816069B2 (de)
AT (1) ATE62407T1 (de)
AU (1) AU589991B2 (de)
CA (1) CA1306949C (de)
DE (1) DE3678640D1 (de)
DK (1) DK404486A (de)
FI (1) FI863435A (de)
GR (1) GR862190B (de)
IE (1) IE58832B1 (de)
IL (1) IL79816A (de)
NO (1) NO174032C (de)
NZ (1) NZ217326A (de)
PH (1) PH23378A (de)
PT (1) PT83241B (de)
ZA (1) ZA866427B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
JP2687401B2 (ja) * 1988-03-22 1997-12-08 藤沢薬品工業株式会社 内服用懸濁剤
HU208495B (en) * 1990-06-27 1993-11-29 Alkaloida Vegyeszeti Gyar Process for producing retarde pharmaceutical compositions
EP0572731A1 (de) * 1992-06-01 1993-12-08 The Procter & Gamble Company Kaubare Zusammensetzung enthaltend ein Dekongestirum
JPH0710747A (ja) * 1993-04-28 1995-01-13 Takeda Chem Ind Ltd 固形製剤およびその製造方法
CA2122286A1 (en) * 1993-04-28 1994-10-29 Hiroshi Matoba Solid preparation and its production
IT1274241B (it) * 1993-12-03 1997-07-15 Smithkline Beecham Farma Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EP0890358B1 (de) * 1997-07-10 2005-02-09 Dr. Gergely & Co. Lösliche, gummihaltige, dragierte Kautablette
JP3143433B2 (ja) * 1998-07-07 2001-03-07 三基商事株式会社 マスキング組成物
WO2000016742A1 (en) * 1998-09-24 2000-03-30 The Procter & Gamble Company Chewable compositions containing dextromethorphan
KR102017550B1 (ko) * 2013-11-13 2019-09-03 내셔널 디펜스 에듀케이션 앤드 리서치 파운데이션 간에 대한 부작용이 없는 신규의 아세트아미노펜 화합물 조성물
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993837A (en) * 1959-07-13 1961-07-25 Frosst & Co Charles E Enteric coated tablets
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
USRE28316E (en) * 1968-09-03 1975-01-21 Entrapment compositions and processes
ZA718014B (en) * 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
JPS5179716A (en) * 1974-12-28 1976-07-12 Shinetsu Chemical Co Kokeiiyakuseizaino seizohoho

Also Published As

Publication number Publication date
IE862267L (en) 1987-02-26
PH23378A (en) 1989-07-26
NO863398L (no) 1987-02-27
PT83241A (en) 1986-09-01
IE58832B1 (en) 1993-11-17
EP0212641A2 (de) 1987-03-04
ZA866427B (en) 1987-10-28
GR862190B (en) 1986-12-23
JPS6251627A (ja) 1987-03-06
EP0212641A3 (en) 1988-03-09
AU589991B2 (en) 1989-10-26
DE3678640D1 (de) 1991-05-16
EP0212641B1 (de) 1991-04-10
DK404486A (da) 1987-02-27
DK404486D0 (da) 1986-08-25
NO174032B (no) 1993-11-29
CA1306949C (en) 1992-09-01
FI863435A0 (fi) 1986-08-25
JPH0816069B2 (ja) 1996-02-21
NO863398D0 (no) 1986-08-25
NZ217326A (en) 1990-02-26
NO174032C (no) 1994-03-09
AU6168086A (en) 1987-03-05
IL79816A0 (en) 1986-11-30
ATE62407T1 (de) 1991-04-15
FI863435A (fi) 1987-02-27
PT83241B (pt) 1988-07-01

Similar Documents

Publication Publication Date Title
IL79816A (en) Pharmaceutical compositions comprising a drug-polymer matrix
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
AU1099288A (en) Drug delivery system and method of making the same
ES2009216A6 (es) Metodo de preparar un derivado de interleucina-lalfa.
IL81472A0 (en) Stabilized formulations of alpha-interferon
NZ212436A (en) D,l-glutamic and d,l-aspartic acid derivatives and pharmaceutical compositions
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
FI945510A0 (fi) Klavulaanihapon diamiinisuolat
NZ227669A (en) Amino acid glycerides and pharmaceutical compositions thereof
HUT49053A (en) Process for producing pharmaceutical composition comprising comt inhibitor as active ingredient and having action on gastrointestinal tract
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void